GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (NAS:APYX) » Definitions » Cyclically Adjusted PS Ratio

Apyx Medical (Apyx Medical) Cyclically Adjusted PS Ratio : 1.22 (As of Apr. 27, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Apyx Medical Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Apyx Medical's current share price is $1.45. Apyx Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $1.19. Apyx Medical's Cyclically Adjusted PS Ratio for today is 1.22.

The historical rank and industry rank for Apyx Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

APYX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.02   Med: 2.66   Max: 14.58
Current: 1.22

During the past years, Apyx Medical's highest Cyclically Adjusted PS Ratio was 14.58. The lowest was 1.02. And the median was 2.66.

APYX's Cyclically Adjusted PS Ratio is ranked better than
68.6% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs APYX: 1.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Apyx Medical's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.423. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1.19 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Apyx Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Apyx Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical Cyclically Adjusted PS Ratio Chart

Apyx Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.11 6.41 10.96 1.99 2.20

Apyx Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 2.42 4.21 2.67 2.20

Competitive Comparison of Apyx Medical's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Apyx Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apyx Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Apyx Medical's Cyclically Adjusted PS Ratio falls into.



Apyx Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Apyx Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.45/1.19
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apyx Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Apyx Medical's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.423/129.4194*129.4194
=0.423

Current CPI (Dec. 2023) = 129.4194.

Apyx Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.367 99.695 0.476
201406 0.328 100.560 0.422
201409 0.382 100.428 0.492
201412 0.418 99.070 0.546
201503 0.299 99.621 0.388
201506 0.298 100.684 0.383
201509 0.289 100.392 0.373
201512 0.260 99.792 0.337
201603 0.287 100.470 0.370
201606 0.344 101.688 0.438
201609 0.372 101.861 0.473
201612 -0.640 101.863 -0.813
201703 0.272 102.862 0.342
201706 0.318 103.349 0.398
201709 0.085 104.136 0.106
201712 0.111 104.011 0.138
201803 0.103 105.290 0.127
201806 0.136 106.317 0.166
201809 0.105 106.507 0.128
201812 0.164 105.998 0.200
201903 0.169 107.251 0.204
201906 0.199 108.070 0.238
201909 0.222 108.329 0.265
201912 0.245 108.420 0.292
202003 0.146 108.902 0.174
202006 0.126 108.767 0.150
202009 0.203 109.815 0.239
202012 0.335 109.897 0.395
202103 0.252 111.754 0.292
202106 0.327 114.631 0.369
202109 0.345 115.734 0.386
202112 0.489 117.630 0.538
202203 0.363 121.301 0.387
202206 0.299 125.017 0.310
202209 0.264 125.227 0.273
202212 0.364 125.222 0.376
202303 0.351 127.348 0.357
202306 0.392 128.729 0.394
202309 0.346 129.860 0.345
202312 0.423 129.419 0.423

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Apyx Medical  (NAS:APYX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Apyx Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Apyx Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Apyx Medical (Apyx Medical) Business Description

Traded in Other Exchanges
Address
5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Executives
Todd Hornsby officer: Executive Vice President 14321 HAWTHORNE DR., CARMEL IN 46033
Goodwin Charles D. Ii director, officer: Chief Executive Officer 5115 ULMERTON ROAD, CLEARWATER FL 33760
Wendy Lauren Levine director 75 KENMARE STREET, APT. 2D, NEW YORK NY 10012
Minnie Baylor-henry director C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803
Tara Semb officer: Chief Financial Officer 5516 RIVERSIDE HEIGHTS WAY, RICHMOND VA 23225
Craig A. Swandal director 5115 ULMERTON ROAD, CLEARWATER FL 33760
Michael Geraghty director 1342 CHERRY HILL ROAD, MENDOTA HEIGHTS MN 55118
Lawrence Waldman director 5115 ULMERTON RD., CLEARWATER FL 33770
John C. Andres director 86 CAPRI LANE, CHATHAM MA 02633
Jay D. Ewers officer: Chief Financial Officer 4 MANHATTANVILLE ROAD, SUITE 106, PURCHASE NY 10577
J Robert Saron director, officer: President
Robert Gershon director, officer: Chief Executive Officer 5115 ULMERTON ROAD, CLEARWATER FL 33760
Mccarthy John J. Iii officer: Chief CommercializationOfficer 23 RINALDO ROAD, NORTHPORT NY 11768
Scott Richard Davidson director C/O GREAT POINT PARTNERS, LLC, 165 MASON STREET, GREENWICH CT 06830
Moshe Citronowicz officer: Vice President of Operations

Apyx Medical (Apyx Medical) Headlines

From GuruFocus